Renal allograft scintigraphy with Tc-99M-DTPA—its role during cyclosporine therapy

Rinaldo Bellomo, Salvatore Berlangieri, Clement Wong, Napier Thomson, Robert C. Atkins

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

There are no accurate noninvasive methods to distinguish renal allograft dysfunction due to rejection or cyclosporine nephrotoxicity. We have studied the value of Tc-99M-DTPA renal scanning in 90 episodes of renal allograft dysfunction occurring in 44 patients subjected to 57 renal biopsies in whom a clear diagnosis could be established. Renal scintigrams were assessed qualitatively and quantitatively by a blinded observer. Rejection was diagnosed when deterioration in perfusion occurred in the presence of maintained or declining radionuclide excretion. The diagnosis of cyclosporine nephrotoxicity was made by exclusion. The final diagnosis was based on the clinical response to therapy and/or the findings on renal biopsy. The scintigraphic diagnosis of rejection had a specificity of 87.9% and significantly contributed to the exclusion of cyclosporine nephrotoxicity (negative predictive value of 90.6%). Furthermore, a scintigraphic diagnosis compatible with cyclosporine nephrotoxicity, in the presence of a drug level above the therapeutic range, indicated a 90.4% probability of true nephrotoxicity. We conclude that, even in cyclosporine-treated renal transplant patients, Tc-99M-DTPA scintigraphy is of clinical value and can be incorporated into an effective diagnostic algorithm for allograft dysfunction.

Original languageEnglish
Pages (from-to)143-145
Number of pages3
JournalTransplantation
Volume53
Issue number1
DOIs
Publication statusPublished - 1 Jan 1992
Externally publishedYes

Cite this

@article{f02c3bcfe74c4f6bac06380af0383f8d,
title = "Renal allograft scintigraphy with Tc-99M-DTPA—its role during cyclosporine therapy",
abstract = "There are no accurate noninvasive methods to distinguish renal allograft dysfunction due to rejection or cyclosporine nephrotoxicity. We have studied the value of Tc-99M-DTPA renal scanning in 90 episodes of renal allograft dysfunction occurring in 44 patients subjected to 57 renal biopsies in whom a clear diagnosis could be established. Renal scintigrams were assessed qualitatively and quantitatively by a blinded observer. Rejection was diagnosed when deterioration in perfusion occurred in the presence of maintained or declining radionuclide excretion. The diagnosis of cyclosporine nephrotoxicity was made by exclusion. The final diagnosis was based on the clinical response to therapy and/or the findings on renal biopsy. The scintigraphic diagnosis of rejection had a specificity of 87.9{\%} and significantly contributed to the exclusion of cyclosporine nephrotoxicity (negative predictive value of 90.6{\%}). Furthermore, a scintigraphic diagnosis compatible with cyclosporine nephrotoxicity, in the presence of a drug level above the therapeutic range, indicated a 90.4{\%} probability of true nephrotoxicity. We conclude that, even in cyclosporine-treated renal transplant patients, Tc-99M-DTPA scintigraphy is of clinical value and can be incorporated into an effective diagnostic algorithm for allograft dysfunction.",
author = "Rinaldo Bellomo and Salvatore Berlangieri and Clement Wong and Napier Thomson and Atkins, {Robert C.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1097/00007890-199201000-00029",
language = "English",
volume = "53",
pages = "143--145",
journal = "Transplantation",
issn = "0041-1337",
publisher = "LWW",
number = "1",

}

Renal allograft scintigraphy with Tc-99M-DTPA—its role during cyclosporine therapy. / Bellomo, Rinaldo; Berlangieri, Salvatore; Wong, Clement; Thomson, Napier; Atkins, Robert C.

In: Transplantation, Vol. 53, No. 1, 01.01.1992, p. 143-145.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Renal allograft scintigraphy with Tc-99M-DTPA—its role during cyclosporine therapy

AU - Bellomo, Rinaldo

AU - Berlangieri, Salvatore

AU - Wong, Clement

AU - Thomson, Napier

AU - Atkins, Robert C.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - There are no accurate noninvasive methods to distinguish renal allograft dysfunction due to rejection or cyclosporine nephrotoxicity. We have studied the value of Tc-99M-DTPA renal scanning in 90 episodes of renal allograft dysfunction occurring in 44 patients subjected to 57 renal biopsies in whom a clear diagnosis could be established. Renal scintigrams were assessed qualitatively and quantitatively by a blinded observer. Rejection was diagnosed when deterioration in perfusion occurred in the presence of maintained or declining radionuclide excretion. The diagnosis of cyclosporine nephrotoxicity was made by exclusion. The final diagnosis was based on the clinical response to therapy and/or the findings on renal biopsy. The scintigraphic diagnosis of rejection had a specificity of 87.9% and significantly contributed to the exclusion of cyclosporine nephrotoxicity (negative predictive value of 90.6%). Furthermore, a scintigraphic diagnosis compatible with cyclosporine nephrotoxicity, in the presence of a drug level above the therapeutic range, indicated a 90.4% probability of true nephrotoxicity. We conclude that, even in cyclosporine-treated renal transplant patients, Tc-99M-DTPA scintigraphy is of clinical value and can be incorporated into an effective diagnostic algorithm for allograft dysfunction.

AB - There are no accurate noninvasive methods to distinguish renal allograft dysfunction due to rejection or cyclosporine nephrotoxicity. We have studied the value of Tc-99M-DTPA renal scanning in 90 episodes of renal allograft dysfunction occurring in 44 patients subjected to 57 renal biopsies in whom a clear diagnosis could be established. Renal scintigrams were assessed qualitatively and quantitatively by a blinded observer. Rejection was diagnosed when deterioration in perfusion occurred in the presence of maintained or declining radionuclide excretion. The diagnosis of cyclosporine nephrotoxicity was made by exclusion. The final diagnosis was based on the clinical response to therapy and/or the findings on renal biopsy. The scintigraphic diagnosis of rejection had a specificity of 87.9% and significantly contributed to the exclusion of cyclosporine nephrotoxicity (negative predictive value of 90.6%). Furthermore, a scintigraphic diagnosis compatible with cyclosporine nephrotoxicity, in the presence of a drug level above the therapeutic range, indicated a 90.4% probability of true nephrotoxicity. We conclude that, even in cyclosporine-treated renal transplant patients, Tc-99M-DTPA scintigraphy is of clinical value and can be incorporated into an effective diagnostic algorithm for allograft dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0026500484&partnerID=8YFLogxK

U2 - 10.1097/00007890-199201000-00029

DO - 10.1097/00007890-199201000-00029

M3 - Article

C2 - 1733063

AN - SCOPUS:0026500484

VL - 53

SP - 143

EP - 145

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -